FTC to study authorized generics

Article

The Federal Trade Commission plans to investigate the likely short- and long-term competitive effects of authorized generic versions of brand drugs. FTC staffers have been authorized to subpoena about 80 drug companies, 10 authorized generic companies, and 100 independent generic manufacturers.

FTC to study authorized generics

The Federal Trade Commission plans to investigate the likely short- and long-term competitive effects of authorized generic versions of brand drugs. FTC staffers have been authorized to subpoena about 80 drug companies, 10 authorized generic companies, and 100 independent generic manufacturers. Public comments to be used to refine the research will be accepted until June 5. A final report is expected sometime next year.

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.